Free Newsletter
Gene therapy triggers rapid weight loss
Professor Matthew During, who teaches in Australia and Ohio State, says he's had significant success with a new gene therapy for obesity and plans to be in the clinic within a year.
Reporting in Nature Medicine, During created a gene therapy that combines brain-derived neurotrophic factor--a protein that regulates weight--with material that spurs autoregulation of the protein. Researchers have also prepared a third ingredient that could knock out the BDNF that could quickly halt its activity if the experiment goes awry. The therapy is injected into the hypothalamus region of the brain.
Researchers found that specially engineered mice suffering from morbid obesity lost 20 percent of their body weight in a matter of weeks. After that initial weight loss, their weights stabilized.
"The efficacy and the degree of weight loss is very dramatic," says During. "We haven't seen that in any study previously... We have very high expectations that this would also work in humans."
- read the story in the New Zealand Herald
Related Articles:
'Obesity gene' could be key to new therapy
Obesity researchers finger cold virus as culprit
'Brown fat' may be a key to curing obesity
Genetic tinkering creates obesity-resistant mice
Comments
I am very interested in learning more about this research. I am located in Las Vegas, NV and I have struggled with weight all my life. If you are looking for people for your research and we know for sure this is a safe therapy, I would like to be a volunteer. Please email me and let me know if that is a possibility.
I have an intrest in this type of reaserch as most members of my family have great difficulty reducing their weight. Most esculate from 100kgs to 180kgs this is of great concern health wise. Age and fitness appears to have an affect on our ability to loose weight or becoming a type 2 diabetic
Post new comment
Paid Research Reports
- Cloud Computing Adoption In The APAC Life Sciences Industry
- Pharmaceutical Licensing Overview
- Stakeholder Opinions: Vaccines in emerging markets (Latin America) - Opportunities in Brazil, Mexico and Argentina
- Pharmaceutical Key Trends 2010
- Commercial Insight: Top 20 Oncology Therapy Brands in Australia
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities

SHARE
WITH: